Validation of the Chinese SF-36 for quality of life assessment in patients with systemic lupus erythematosus

Abstract

We studied the reliability and validity of the Chinese Short-Form 36 Health Survey (SF-36) in a cross sectional study of patients with systemic lupus erythematosus (SLE). Sixty-nine consecutive subjects completed a questionnaire containing the Chinese SF-36 twice within 14 d. Disease activity and damage were assessed using the British Isles Lupus Activity Group (BILAG) and SLICC/ACR Damage Index (DI) scales, respectively. Internal consistency was assessed using Cronbach's alpha, reliability using Spearman's correlation and repeatability coefficients, and relationships between SF-36, BILAG and DI scores using Spearman's correlation.

The Chinese SF-36 showed high internal consistency (ά =0.72– 0.91) and good reliability, with correlations exceeding 0.70 for 7 scales and mean scale score differences of < 2 points for 6 scales. SF-36 scores correlated weakly with BILAG scores (–0.27 to –0.41) and DI scores (–0.24 to –0.35), and subjects' mean SF-36 scores were 6 – 24 points lower than the general population, supporting construct validity of the SP-36.

These data suggest that the Chinese SF-36 is a reliable and valid measure of quality of life in patients with SLE.

Keywords

quality of life systemic lupus erythematosus language Asia Singapore

Get full access to this article

View all access options for this article.

References

Strand V , Gladman D , Isenberg D et al. Outcome measures to be used in clinical trials in systemic lupus erythematosus . J Rheumatol 1999; 26: 490 –497 .

Gladman D , Urowitz M , Fortin P et al. Systemic Lupus International Collaborating Clinics conference on assessment of lupus flare and quality of life measures in SLE. Systemic Lupus International Collaborating Clinics Group . J Rheumatol 1996; 23: 1953–1955 .

Gladman DD , Urowitz MB , Gough J , MacKinnon . Fibromyalgia is a major contributor to quality of life in lupus . J Rheumatol 1997; 24: 2145–2148 .

Stoll T , Gordon C , Seifert B et al. Consistency and validity of patient administered assessment of quality of life by the MOS SF-36; its association with disease activity and damage in patients with systemic lupus erythematosus . J Rheumatol 1997; 24: 1608–1614 .

Thumboo J , Fong KY , Ng TP et al. Validation of the MOS SF-36 for quality of life assessment of systemic lupus erythematosus patients in Singapore . J Rheumatol 1999; 26: 97–102 .

Thumboo J , Fong KY , Ng TP et al. Initial construct cross-cultural validation of the short form 36 for quality of life assessment of systemic lupus erythematosus patients in Singapore . Ann Acad Med Singapore 1997; 26: 282–284 .

Lam CL , Gandek B , Ren XS , Chan MS . Tests of scaling assumptions and construct validity of the Chinese (HK) version of the SF-36 Health Survey . J Clin Epidemiol 1998; 51: 1139–1147 .

Tan EM , Cohen AS , Fries JF et al. The 1982 revised criteria for the classification of SLE . Arthritis Rheum 1982; 25: 1271–1277 .

Ware JE . SF-36 health survey: manual and interpretation guide. The Health Institute, New England Medical Center: Boston , 1993.

10.

Hay EM , Bacon PA , Gordon C et al. The BILAG Index: a reliable and valid instrument for measuring clinical disease activity in systemic lupus erythematosus . Q J Med 1993; 86: 447–458 .

11.

Stoll T , Stucki G , Malik J et al. Further validation of the BILAG disease activity index in patients with systemic lupus erythematosus . Ann Rheum Dis 1996; 55: 756–760 .

12.

Gladman D , Ginzler E , Goldsmith C et al. The development and initial validation of the SLICC/ACR damage index for SLE . Arthritis Rheum 1996; 39: 363–369 .

13.

Bland JM , Altman DG . Statistics notes: Cronbach's alpha . Br Med J 1997; 314: 572-572 .

14.

Bland JG , Altman DG . Statistical methods for assessing agreement between two methods of clinical measurement . Lancet 1986; 1: 307–310 .

15.

Gladman DD , Urowitz MB , Ong A et al. Lack of correlation among the three outcomes describing SLE: disease activity, damage and quality of life . Clin Exp Rheum 1996 14: 305–308 .

16.

Ware JE , Gandek B . Methods for testing data quality, scaling assumptions, and reliability: the IQOLA project approach . J Clin Epidemiol 1998; 51: 945–952 .

17.

Thumboo J , Fong KY , Ng TP et al. The SF-36 is sensitive to changes in quality of life in SLE patients. 1998 American College of Rheumatology National Meeting . Arthritis Rheum 1998; 41(Suppl); S225-S225 .

18.

Guillemin F , Bombardier C , Beaton D . Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines . J Clin Epidemiol 1993; 46: 1417–1432 .

19.

Ruta DA , Abdalla MI , Garratt AM et al. SF-36 health survey questionnaire: I. reliability in two patient based studies . Qual Health Care 1994; 3: 180–185 .

20.

Ware JE , Kosinski M . SF-36 health survey (version 2.0) technical note. Health Assessment Lab: Boston, MA , 20 September 1996 (updated 27 September 1997).

21.

Mook J , Kleijn WC , van-de-Ploeg HM . Symptom positively and negatively worded items in two popular self-report inventories of anxiety and depression . Psychol Rep 1991; 69: 551–560 .

22.

Rummel RJ . Applied Factor Analysis. Northwestern University Press: Chicago , 1970, 369-369.